Crossref
Psychedelic Therapies in the United States — Balancing State and Federal Oversight
New England Journal of Medicine · 18.06.2026 · 394 (23) · 2281-2283
DOI: 10.1056/nejmp2518374 ↗Kurz gefasst
Fachartikel in der Zeitschrift New England Journal of Medicine, erschienen am 18.06.2026. Verfasst von Marcus Hughes. Beteiligte Einrichtung: Department of Psychiatry, Yale School of Medicine, New Haven, CT. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Psychiatry, Yale School of Medicine, New Haven, CT.
- Yale Depression Research Program, Yale School of Medicine, New Haven, CT.
Zitieren
APA
Hughes, M. (2026). Psychedelic Therapies in the United States — Balancing State and Federal Oversight. New England Journal of Medicine, 394(23), 2281-2283. https://doi.org/10.1056/nejmp2518374
Vancouver
Hughes M. Psychedelic Therapies in the United States — Balancing State and Federal Oversight. New England Journal of Medicine. 2026;394(23):2281-2283. doi:10.1056/nejmp2518374
BibTeX
@article{Hughes2026,
author = {Hughes, Marcus},
title = {Psychedelic Therapies in the United States — Balancing State and Federal Oversight},
journal = {New England Journal of Medicine},
year = {2026},
volume = {394},
number = {23},
pages = {2281--2283},
doi = {10.1056/nejmp2518374}
}
EUVIMED